Trial Condition(s):

Allergic Rhinitis

A study to evaluate cooling sensation of an allergy product in adults with a history of allergies

Bayer Identifier:

21048

ClinicalTrials.gov Identifier:

NCT04162795

EudraCT Number:

Not Available

Study Completed

Trial Purpose

In this study, researchers were primarily interested in evaluating the level of agreement of cooling sensation provided by this chewable, flavored, allergy medicine. Participants joining this study received one test drug tablet and were asked to chew completely before swallowing the drug. A questionnaire was used to collect the feedback from participants. The study involved only one (1) visit and participant stayed in this study for about 60-75 minutes to evaluate the cooling sensation as well as other sensory attributes perceived in the mouth, nose and throat.

Inclusion Criteria
- Female or male adults aged 18 to 65 years of age inclusive
- Were in good general health
- Previous self-reported sufferers of upper respiratory allergies who at the time of the study are either asymptomatic, symptomatic but not treating and agree to use study medication or symptomatic and treating with an allergy medicine that is not an antihistamine
- Agreed to not use antihistamine products 24 hours before and after the treatment
- Willing to avoid eating food or candy (other than crackers consumed during testing), drinking any liquid other than water, gum chewing and teeth brushing one hour prior to testing
Exclusion Criteria
- Individuals who had used oral/systemic medications 24 hours before the first administration of test product
- Individuals who used medications which might influence taste perception
- Individuals who had received or used an investigational new drug in the last 30 days or had been an active participant in another clinical or market research study in the last 30 days
- Women who were pregnant or thinking of becoming pregnant or were nursing
- Participants with congestion at the time of study visit
- Any self-reported symptoms or conditions that might interfere with the participants ability to complete the evaluation of the product on testing day
- Any current medical condition that in the opinion of the Investigator or designee might interfere with normal taste and/or temperature perception (e.g., active common cold, sinus infection, bronchial infection, adenoids, paresthesia etc.)
- History of alcohol or drug abuse
- History of hypersensitivity or allergic reactions to any ingredients in the test product
- Individuals with a history of glaucoma, liver or kidney disease, respiratory conditions such as chronic bronchitis or swallowing difficulties
- Individuals who were currently wearing any kind of dental braces or with dental work or had cavities and associated pain that might affect their ability to chew a tablet

Trial Summary

Enrollment Goal
468
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
CLARITIN (Loratadine, BAY76-2211)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Focus Pointe Global

Teaneck, United States, 07666

Status
Completed
 

Trial Design